prostate cancer
New Standard of Care for Metastatic Castration-Sensitive Prostate Cancer?
Adding niraparib (Zejula, GSK) to abiraterone acetate (Akeega, Janssen) plus prednisone (AAP) can help improve ...
JULY 23, 2025
FDA Approves Nubeqa for Metastatic Castration-Sensitive Prostate Cancer
The FDA has approved darolutamide (Nubeqa, Bayer) for metastatic castration-sensitive prostate cancer ...
JUNE 3, 2025
FDA Expands Pluvicto’s Metastatic Castration-Resistant Prostate Cancer Indication
The FDA expanded the indication for lutetium Lu 177 vipivotide tetraxetan (Pluvicto, Novartis) to include adults ...
APRIL 2, 2025
Exercise Can Lessen Fatigue in Prostate Cancer Patients Undergoing ADT
Results from a new study demonstrate that a structured exercise program can decrease fatigue in patients with ...
MARCH 31, 2025
Early Survival Benefit Validates Addition of Radium-244 to Metastatic Prostate Cancer
In men with metastatic castration-resistant prostate cancer (mCRPC), the addition of Radium-233 (Ra233) (Xofigo, ...
OCTOBER 30, 2024
FDA Approves First Interchangeable Biosimilars to Xgeva and Prolia
The FDA approved the first interchangeable biosimilar to Prolia (denosumab) and Xgeva (denosumab). Sandoz’s ...
MARCH 6, 2024
FDA Approves Xtandi for Nonmetastatic Castration-Sensitive Prostate Cancer With Biochemical Recurrence
The FDA approved enzalutamide (Xtandi, Astellas Pharma) for nonmetastatic castration-sensitive prostate cancer ...
NOVEMBER 18, 2023
The Unequal Promise of Prostate Cancer Therapy
Triplet therapies that combine androgen deprivation therapy, infusion chemotherapy and oral hormones may extend the ...
AUGUST 21, 2023
Genetic Risk Score Predicts Prostate Cancer Likelihood, Severity in Black Men
A genetic risk score can determine both the likelihood and severity of prostate cancer in men of African ...
APRIL 24, 2023
Adding Talazoparib to Enzalutamide in mCRPC Improves Outcomes
In patients with metastatic, castration-resistant prostate cancer, adding the PARP inhibitor talazoparib (Talzenna, ...
MARCH 10, 2023
Gut Bacteria Linked to Prostate Cancer in Prospective Study
Gut bacteria of men with confirmed prostate cancer differ significantly from those with benign biopsies, according ...
SEPTEMBER 14, 2022
New Approval for Darolutamide
The FDA approved an additional indication of darolutamide (Nubeqa, Bayer) in combination with docetaxel for the ...
AUGUST 18, 2022
